386 related articles for article (PubMed ID: 17566522)
21. Role of coagulation inhibitors in inflammation.
Esmon CT
Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
[TBL] [Abstract][Full Text] [Related]
22. [Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells].
Takeya H; Suzuki K
Rinsho Byori; 1994 Apr; 42(4):333-9. PubMed ID: 8176840
[TBL] [Abstract][Full Text] [Related]
23. The suppression of the coagulation of nonanticoagulated whole blood in vitro by human umbilical endothelial cells cultivated on microcarriers is not dependent on protein C activation.
Kohler HP; Müller M; Bombeli T; Straub PW; Haeberli A
Thromb Haemost; 1995 Apr; 73(4):719-24. PubMed ID: 7495085
[TBL] [Abstract][Full Text] [Related]
24. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients.
Levi M; van der Poll T
Semin Thromb Hemost; 2008 Jul; 34(5):459-68. PubMed ID: 18956286
[TBL] [Abstract][Full Text] [Related]
25. Regulation of inflammation by the protein C system.
Weiler H
Crit Care Med; 2010 Feb; 38(2 Suppl):S18-25. PubMed ID: 20083909
[TBL] [Abstract][Full Text] [Related]
26. The anticoagulant protein C pathway.
Dahlbäck B; Villoutreix BO
FEBS Lett; 2005 Jun; 579(15):3310-6. PubMed ID: 15943976
[TBL] [Abstract][Full Text] [Related]
27. Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications.
Okajima K
Clin Chem Lab Med; 2004 Feb; 42(2):132-41. PubMed ID: 15061350
[TBL] [Abstract][Full Text] [Related]
28. The coagulant response in sepsis and inflammation.
Levi M
Hamostaseologie; 2010 Jan; 30(1):10-2, 14-6. PubMed ID: 20162247
[TBL] [Abstract][Full Text] [Related]
29. The protein C pathway and sepsis.
Della Valle P; Pavani G; D'Angelo A
Thromb Res; 2012 Mar; 129(3):296-300. PubMed ID: 22154246
[TBL] [Abstract][Full Text] [Related]
30. Heparin-protein C interaction.
Comp PC
Nouv Rev Fr Hematol (1978); 1984; 26(4):239-42. PubMed ID: 6089102
[TBL] [Abstract][Full Text] [Related]
31. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
Wu KK; Matijevic-Aleksic N
Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
[TBL] [Abstract][Full Text] [Related]
32. [Protein C: mechanisms of activation and anticoagulant effect].
Kogan AE; Strukova SM
Biokhimiia; 1993 Jun; 58(6):827-44. PubMed ID: 8364108
[TBL] [Abstract][Full Text] [Related]
33. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.
Tanaka KA; Fernández JA; Marzec UM; Kelly AB; Mohri M; Griffin JH; Hanson SR; Gruber A
Br J Haematol; 2006 Jan; 132(2):197-203. PubMed ID: 16398653
[TBL] [Abstract][Full Text] [Related]
34. The up-regulation of IL-6 and IL-8 in human endothelial cells by activated protein C.
Hooper WC; Phillips DJ; Renshaw MA; Evatt BL; Benson JM
J Immunol; 1998 Sep; 161(5):2567-73. PubMed ID: 9725257
[TBL] [Abstract][Full Text] [Related]
35. The protein C pathway.
Esmon CT
Chest; 2003 Sep; 124(3 Suppl):26S-32S. PubMed ID: 12970121
[TBL] [Abstract][Full Text] [Related]
36. Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H; Falanga A
Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
[TBL] [Abstract][Full Text] [Related]
37. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
38. Natural anticoagulant inhibitors: activated Protein C.
Aird WC
Best Pract Res Clin Haematol; 2004 Mar; 17(1):161-82. PubMed ID: 15171965
[TBL] [Abstract][Full Text] [Related]
39. Effects of activated protein C on coagulation and fibrinolysis in rabbits with endotoxin induced acute lung injury.
He HY; Wang C; Pang BS
Chin Med J (Engl); 2008 Dec; 121(24):2561-5. PubMed ID: 19187596
[TBL] [Abstract][Full Text] [Related]
40. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.
Richardson MA; Gupta A; O'Brien LA; Berg DT; Gerlitz B; Syed S; Sharma GR; Cramer MS; Heuer JG; Galbreath EJ; Grinnell BW
J Pharmacol Exp Ther; 2008 Apr; 325(1):17-26. PubMed ID: 18182560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
